0
     

Report Added
Report already added
Dyslexia Treatment Market – Forecast to 2027

Dyslexia Treatment Market – Forecast to 2027

Dyslexia Treatment Market – Forecast to 2027

Market Overview
As per the MRFR analysis, the global dyslexia treatment market is projected to register a significant market expansion at a notable CAGR of 7.10% during the review period to surpass USD 38,514.67 million by the end of 2027. Research has shown that dyslexia happen due to the way the brain cerebrum processes data. So that is the reason perusing seems like such sluggish, difficult work. Individuals with dyslexia frequently track down ways of working around their handicap, so nobody will realize they're having trouble. This might save some humiliation, however, getting help could make school and peruse more straightforward. The vast majority are analyzed as children, yet it's to be expected for youngsters or even grown-ups to be analyzed.

The global dyslexia treatment market is expected to register a healthy market expansion owing to the highest market value of USD 23,682.69 million in 2020. The development of the worldwide dyslexia treatment market is driven by the rising predominance of dyslexia and expanding application improvement exercises to treat dyslexia and among others. However, it may, the absence of mindfulness about dyslexia, its side effects, and underdiagnosis is a limiting element for the dyslexia treatment market. Then again, coordinated effort with schools, universities, and non-benefit associations gives rewarding open doors to players working in the worldwide dyslexia treatment market.

Market Segmentation
The global Dyslexia Treatment Market has been classified in terms of type, application, end-user, and region.
The type of segment categorizes the market into Phonological Dyslexia, Surface Dyslexia, and Others. Based on Application, the market is bifurcated into Treatment and Diagnosis. The end-user segment has been classified in terms of Specialty centers, Home Care, Hospitals & Clinics, and Others.

Regional Analysis
The global dyslexia treatment market is classified, geographically into five major regions North America, Europe, Asia-Pacific, and the Rest of the World.
North America represented the biggest market portion of 5.79% is because of the presence of created medical services framework, positive government approaches, and presence of significant key organizations central command in the region, for example, Jubilant Cadista (US) and Speechify (US), and high predominance of dyslexia are driving the market in the area. For example, as per the Dyslexia Center of Utah, one of every five understudies, i.e., 15%-20% of the US populace, have a learning-based incapacity, most regularly dyslexia.

Europe represented a considerable share of the worldwide dyslexia treatment and analysis market. Like North America, Europe additionally faces a high commonness of dyslexia. Asia-Pacific is the quickest developing territorial market for the dyslexia treatment and conclusion market as it is growing quickly and has seen the rise of numerous players. There is likewise a high predominance of dyslexia driving the market development. As indicated by the Department of Biotechnology, in 2019, around 35 million kids in India were thought to be dyslexics. Moreover, provinces in the Asia-Pacific locales have additionally fostered their own dyslexia evaluation tests to accurately recognize the dyslexic populace inside the nation and give proper consideration.

Major Players
The key Companies mentioned in the dyslexia treatment market are Pfizer, Inc. (US), Novartis AG (Switzerland), Lyfta (UK), GlaxoSmithKline (UK), Teva Pharmaceutical Industries Ltd (Israel), Speechify Inc. (US), Jubilant Pharma Limited (Singapore), Lingit AS (Norway), Soli (UK), Eli Lilly & Company (US), RPG Life Sciences Ltd (India), Hopalai D.O.O. (Slovenia).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF DYSLEXIA
4.2.2 INCREASING APP DEVELOPMENT ACTIVITIES TO TREAT DYSLEXIA
4.2.3 GROWING NUMBER OF VITUAL REALITY-BASED EDUCATIONAL SOFTWARE
4.3 RESTRAINT
4.3.1 LACK OF AWARENESS ABOUT DYSLEXIA, ITS SYMPTOMS AND UNDERDIAGNOSIS
4.4 OPPORTUNITY
4.4.1 COLLABORATION WITH SCHOOLS, COLLEGES AND NON PROFIT ORGANIZATIONS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 RESEARCH & DEVELOPMENT
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION
5.1.4 MARKETING & SALES
5.1.5 POST-SALES MONITORING
5.1.6 INPUTS
5.1.7 SOFTWARE DEVELOPMENT PROCESSES
5.1.8 OUTPUT
5.1.9 MARKETING AND DISTRIBUTION
5.1.10 POST-SELLING SERVICES
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.4 DYSLEXIA DIAGNOSIS
5.5 DYSLEXIA TREATMENT
5.6 STANDARD PAPER TESTS VS ELECTRONIC VERSIONS
5.6.1 TESTS FOR DYSLEXIA AND LEARNING DISABILITIES (PRE-SCHOOLERS)
6 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TYPE
6.1 OVERVIEW
6.2 PHONOLOGICAL DYSLEXIA
6.3 SURFACE DYSLEXIA
6.4 OTHERS
7 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TREATMENT & DIAGNOSIS
7.1 OVERVIEW
7.2 TREATMENT
7.2.1 MEDICATIONS
7.2.1.1 ANTIHISTAMINES
7.2.1.2 CENTRAL NERVOUS STIMULANT
7.2.1.3 ANTI-MYOCLONIC
7.2.1.4 ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG
7.2.1.5 OTHERS
7.2.2 TOOLS
7.2.2.1 E-READERS AND TABLETS
7.2.2.2 APPS
7.2.2.3 SMARTPENS
7.2.2.4 OTHERS
7.3 DIAGNOSIS
7.3.1 PAPER-BASED
7.3.2 DIGITAL-BASED
8 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY END USER
8.1 OVERVIEW
8.2 SPECIALTY CENTER
8.3 HOME CARE
8.4 HOSPITALS & CLINICS
8.5 OTHERS
9 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
9.5.3 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 COMPETITIVE OVERVIEW
10.2 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.4 COMPETITIVE BENCHMARKING
10.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES
10.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
10.7 MAJOR PLAYERS FINANCIAL MATRIX
10.7.1 REVENUE OF MAJOR PLAYERS, 2020
10.7.2 R&D EXPENDITURE, 2020
11 COMPANY PROFILES
11.1 PFIZER INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SPEECHIFY INC.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS.
11.2.5 KEY STRATEGIES
11.3 JUBILANT PHARMA LIMITED
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 LINGIT AS
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 SOLI
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 NOVARTIS AG
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 LYFTA
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 GLAXOSMITHKLINE
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 ELI LILLY & COMPANY
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
11.11 RPG LIFE SCIENCES LTD
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS/SERVICES OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIES
11.12 HOPALAI D.O.O.
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS/SERVICES OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 APPLICATION DEVELPOPED SPECIFICALLY FOR DYSLEXIA
TABLE 4 FREE APPS FOR DYSLEXIA
TABLE 5 DYSLEXIA SCHOOLS IN CANADA
TABLE 6 DYSLEXIA SCHOOLS IN THE UK
TABLE 7 DYSLEXIA SCHOOLS IN THE UK
TABLE 8 DYSLEXIA AND LEARNING DISABILITIES TESTS FOR PRE-SCHOOLERS (BIRTH – 5 YEARS):
TABLE 9 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY SHOULDER TYPE, 2018-2027 (USD MILLION)
TABLE 10 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY PHONOLOGICAL DYSLEXIA, 2018–2027 (USD MILLION)
TABLE 11 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SURFACE DYSLEXIA, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 14 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY REGION, 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 18 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTIHISTAMINES, BY REGION, 2018–2027 (USD MILLION)
TABLE 19 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR CENTRAL NERVOUS STIMULANT, BY REGION, 2018–2027 (USD MILLION)
TABLE 20 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTI-MYOCLONIC, BY REGION, 2018–2027 (USD MILLION)
TABLE 21 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG, BY REGION, 2018–2027 (USD MILLION)
TABLE 22 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 23 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY REGION, 2018–2027 (USD MILLION)
TABLE 24 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 25 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR E-READERS AND TABLETS, BY REGION, 2018–2027 (USD MILLION)
TABLE 26 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR APPS, BY REGION, 2018–2027 (USD MILLION)
TABLE 27 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SMARTPENS, BY REGION, 2018–2027 (USD MILLION)
TABLE 28 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 29 COMMON CLINICAL TESTS PERFORMED TO DIAGNOSE DYSLEXIA
TABLE 30 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY REGION, 2018–2027 (USD MILLION)
TABLE 31 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 32 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR PAPER-BASED, BY REGION, 2018–2027 (USD MILLION)
TABLE 33 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIGITAL-BASED, BY REGION, 2018–2027 (USD MILLION)
TABLE 34 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 35 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SPECIALTY CENTER, BY REGION, 2018–2027 (USD MILLION)
TABLE 36 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOME CARE, BY REGION, 2018–2027 (USD MILLION)
TABLE 37 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2027 (USD MILLION)
TABLE 38 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 39 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 48 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 49 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 50 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 51 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 52 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 53 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 54 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 55 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 56 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 57 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 58 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 59 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 60 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 61 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 62 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 64 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 65 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 66 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 68 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 69 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 70 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 71 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 72 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 73 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 74 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 76 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 77 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 78 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 79 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 80 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 81 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 82 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 83 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 84 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 85 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 86 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 87 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 88 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 89 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 90 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 91 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 92 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 93 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 94 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 95 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 96 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 97 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 98 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 99 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 100 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 101 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 102 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 103 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 104 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 105 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 106 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 107 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 108 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 109 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 110 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 111 ASIA PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 112 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 113 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 114 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 115 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 116 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 117 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 118 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 119 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 120 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 121 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 122 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 123 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 124 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 125 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 126 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 127 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 128 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 129 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 130 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 131 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 132 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 133 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 134 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 135 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 136 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 137 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 138 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 139 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 140 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 141 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 142 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 143 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 144 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 145 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 146 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 147 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 148 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 149 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 150 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 151 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 152 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 153 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 154 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 156 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 157 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 158 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2018–2027 (USD MILLION)
TABLE 159 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 160 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 161 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 162 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 163 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 164 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 165 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 166 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 167 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 168 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 175 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 176 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 177 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 178 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 179 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 180 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 181 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 182 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 183 AFRICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 184 AFRICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2018–2027 (USD MILLION)
TABLE 185 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)
TABLE 186 AFRICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018–2027 (USD MILLION)
TABLE 187 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 188 AFRICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)
TABLE 189 AFRICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 190 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
TABLE 191 THE MOST ACTIVE PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
TABLE 192 NEW PRODUCT DEVELOPMENTS/LAUNCHES/PRODUCT LICENSING AGREEMENTS
TABLE 193 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
TABLE 194 PFIZER INC.: PRODUCTS OFFERED
TABLE 195 SPEECHIFY INC.: PRODUCTS OFFERED
TABLE 196 JUBILANT PHARMA LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 197 LINGIT AS: PRODUCTS OFFERED
TABLE 198 LINGIT AS: KEY DEVELOPMENTS
TABLE 199 SOLI: PRODUCTS/SERVICES OFFERED
TABLE 200 NOVARTIS AG: PRODUCTS/SERVICES OFFERED
TABLE 201 LYFTA: PRODUCTS/SERVICES OFFERED
TABLE 202 LYFTA: KEY DEVELOPMENTS
TABLE 203 GLAXOSMITHKLINE: PRODUCTS OFFERED
TABLE 204 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED
TABLE 205 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS
TABLE 206 ELI LILLY & COMPANY: PRODUCTS/SERVICES OFFERED
TABLE 207 RPG LIFE SCIENCES LTD: PRODUCTS/SERVICES OFFERED
TABLE 208 HOPALAI D.O.O.: PRODUCTS/SERVICES OFFERED

Report Title: Dyslexia Treatment Market – Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Genome-Based Drug Companies in China

Genome-Based Drug Companies in China

Biologics Companies in China

Biologics Companies in China

Bladder Cancer Treatment Drugs Companies in China

Bladder Cancer Treatment Drugs Companies in China

Health Care  Companies in China

Health Care Companies in China

Cardiovascular Drugs Companies in China

Cardiovascular Drugs Companies in China

Cancer Treatment Drugs Companies in China

Cancer Treatment Drugs Companies in China